Benjamin Trzaskoma

Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death

Edward Abraham, Pierre‐François Laterre, Rekha Garg et al. · New England Journal of Medicine · 2005 · 890 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial

Clifton O. Bingham, R. John Looney, Atul Deodhar et al. · Arthritis & Rheumatism · 2009 · 462 citations

Life Sciences, Immunology, Internal Medicine +17

Early changes in organ function predict eventual survival in severe sepsis*

Mitchell M. Levy, William L. Macias, Jean‐Louis Vincent et al. · Critical Care Medicine · 2005 · 358 citations

Medicine, Respiratory Therapy, Critical Care Medicine +16

Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study

Thomas B. Casale, Allan T. Luskin, William W. Busse et al. · The Journal of Allergy and Clinical Immunology In Practice · 2018 · 276 citations

Medicine, Internal Medicine, Pharmacotherapy +14

A randomized multicenter study evaluating Xolair persistence of response after long-term therapy

Dennis K. Ledford, William W. Busse, Benjamin Trzaskoma et al. · Journal of Allergy and Clinical Immunology · 2016 · 222 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14